unknown
Stage
1
Investors
About
Biomea Fusion develops novel covalent small molecule therapies designed to treat serious and life-threatening diseases by targeting key mechanisms involved in disease progression.
Explore Biomea Fusion's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.